Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal.
Raugi DN, Diallo K, Diallo MB, Faye D, Cisse O, Smith RA, Sall F, Sall EHI, Faye K, Diatta JP, Diaw B, Sambou J, Malomar JJ, Hawes SE, Seydi M, Gottlieb GS; University of Washington-Senegal HIV-2 Study Group.
Raugi DN, et al. Among authors: diallo k, diallo mb.
Trials. 2021 Dec 18;22(1):931. doi: 10.1186/s13063-021-05902-5.
Trials. 2021.
PMID: 34922614
Free PMC article.
Clinical Trial.